The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Yohei Sotomi
Showing 1-20 of 22 articles
Coronary vasomotion after treatment with drug-coated balloons or drug-eluting stents: a prospective, open-label, single-centre randomised trial
Kawai T,
Watanabe T,
Yamada T,
Morita T,
Furukawa Y,
Tamaki S,
Kawasaki M,
Kikuchi A,
Seo M,
Nakamura J,
Tachibana K,
Kida H,
Sotomi Y,
Sakata Y,
Fukunami M
June 3, 2022 | 10.4244/EIJ-D-21-00636
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
Miyazaki Y,
Muramatsu T,
Asano T,
Katagiri Y,
Sotomi Y,
Nakatani S,
Takahashi K,
Kogame N,
Higuchi Y,
Ishikawa M,
Kyono H,
Yano M,
Ozaki Y,
Serruys P,
Okamura T,
Onuma Y
March 19, 2021 | 10.4244/EIJ-D-18-00902
Impact of the one-year angioscopic findings on long-term clinical events in 504 patients treated with first-generation or second-generation drug-eluting stents: the DESNOTE-X study
Sotomi Y,
Suzuki S,
Kobayashi T,
Hamanaka Y,
Nakatani S,
Hirata A,
Takeda Y,
Ueda Y,
Sakata Y,
Higuchi Y
September 20, 2019 | 10.4244/EIJ-D-18-00660
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y,
Onuma Y,
Liu S,
Asano T,
Eggermont J,
Katagiri Y,
Cavalcante R,
de Winter RJ,
Wykrzykowska JJ,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Dijkstra J,
Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T,
Katagiri Y,
Collet C,
Tenekecioglu E,
Miyazaki Y,
Sotomi Y,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska JJ,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Reiber J,
von Birgelen C,
Sabaté M,
Onuma Y,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial
Tijssen R,
Kraak R,
Elias J,
van Dongen I,
Kalkman D,
Nassif M,
Sotomi Y,
Asano T,
Katagiri Y,
Collet C,
Piek J,
Henriques J,
de Winter RJ,
Tijssen J,
Onuma Y,
Serruys P,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-17-01152
Difference in haemodynamic microenvironment in vessels scaffolded with Absorb BVS and Mirage BRMS: insights from a preclinical endothelial shear stress study
Tenekecioglu E,
Torii R,
Bourantas C,
Sotomi Y,
Cavalcante R,
Zeng Y,
Collet C,
Crake T,
Suwannasom P,
Onuma Y,
Serruys P
December 20, 2017 | 10.4244/EIJ-D-17-00283
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Sotomi Y,
Onuma Y,
Miyazaki Y,
Asano T,
Katagiri Y,
Tenekecioglu E,
Jonker H,
Dijkstra J,
de Winter RJ,
Wykrzykowska JJ,
Stone G,
Popma J,
Kozuma K,
Tanabe K,
Serruys P,
Kimura T
August 4, 2017 | 10.4244/EIJ-D-17-00070
First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis
Suwannasom P,
Sotomi Y,
Corti R,
Kurz D,
Roffi M,
von Birgelen C,
Buzzi S,
Zucker A,
Dijkstra J,
Wykrzykowska JJ,
de Winter RJ,
Windecker S,
Onuma Y,
Serruys P,
Daemen J,
Räber L
April 20, 2017 | 10.4244/EIJ-D-16-00975
Five-year follow-up of underexpanded and overexpanded bioresorbable scaffolds: self-correction and impact on shear stress
Torii R,
Tenekecioglu E,
Bourantas C,
Poon E,
Thondapu V,
Gijsen F,
Sotomi Y,
Onuma Y,
Barlis P,
Ooi A,
Serruys P
April 20, 2017 | 10.4244/EIJ-D-17-00081
Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study
Suwannasom P,
Sotomi Y,
Asano T,
Koon J,
Tateishi H,
Zeng Y,
Tenekecioglu E,
Wykrzykowska JJ,
Foin N,
de Winter RJ,
Ormiston J,
Serruys P,
Onuma Y
April 7, 2017 | 10.4244/EIJ-D-16-00740
Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial
Cavalcante R,
Onuma Y,
Sotomi Y,
Collet C,
Thomsen B,
Rogers C,
Zeng Y,
Tenekecioglu E,
Asano T,
Miyazaki Y,
Abdelghani M,
Morel M,
Serruys P
March 20, 2017 | 10.4244/EIJ-D-16-00612
Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?
Sotomi Y,
Miyazaki Y,
Collet C,
Asano T,
Suwannasom P,
Thijssen J,
de Winter RJ,
Waksman R,
Lipinski M,
Onuma Y,
Serruys P
March 20, 2017 | 10.4244/EIJ-D-16-00472
Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial
Ohya M,
Kadota K,
Sotomi Y,
Kozuma K,
Tanabe K,
Uematsu M,
Kawasaki T,
Morino Y,
Tobaru T,
Nakao K,
Tachibana K,
Kishi K,
Shibata Y,
Ying S,
Kusano H,
Stone G,
Popma J,
Onuma Y,
Serruys P,
Kimura T
February 20, 2017 | 10.4244/EIJ-D-16-00359
Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging
Sotomi Y,
Suwannasom P,
Serruys P,
Onuma Y
February 20, 2017 | 10.4244/EIJ-D-16-00471
Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up
Nakatani S,
Sotomi Y,
Ishibashi Y,
Grundeken M.J,
Tateishi H,
Tenekecioglu E,
Zeng Y,
Suwannasom P,
Regar E,
Radu M,
Räber L,
Bezerra H,
Costa M,
Fitzgerald P,
Prati F,
Costa R,
Dijkstra J,
Kimura T,
Kozuma K,
Tanabe K,
Akasaka T,
Di Mario C,
Serruys P,
Onuma Y
December 20, 2016 | 10.4244/EIJY15M10_03
Preclinical assessment of the endothelial shear stress in porcine-based models following implantation of two different bioresorbable scaffolds: effect of scaffold design on the local haemodynamic micro-environment
Tenekecioglu E,
Torii R,
Bourantas C,
Crake T,
Zeng Y,
Sotomi Y,
Onuma Y,
Yılmaz M,
Santoso T,
Serruys P
November 20, 2016 | 10.4244/EIJY16M05_01
Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial
Onuma Y,
Sotomi Y,
Shiomi H,
Ozaki Y,
Namiki A,
Yasuda S,
Ueno T,
Ando K,
Furuya J,
Igarashi K,
Kozuma K,
Tanabe K,
Kusano H,
Rapoza R,
Popma J,
Stone G,
Simonton C,
Serruys P,
Kimura T
October 20, 2016 | 10.4244/EIJY16M09_01
Quantification by optical coherence tomography imaging of the ablation volume obtained with the Orbital Atherectomy System in calcified coronary lesions
Sotomi Y,
Cavalcante R,
Shlofmitz R,
Suwannasom P,
Tateishi H,
Tenekecioglu E,
Zheng Y,
Abdelghani M,
de Winter RJ,
Wykrzykowska JJ,
Onuma Y,
Serruys P
October 20, 2016 | 10.4244/EIJV12I9A184
Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
Sotomi Y,
Onuma Y,
Suwannasom P,
Tateishi H,
Tenekecioglu E,
Zeng Y,
Cavalcante R,
Jonker H,
Dijkstra J,
Foin N,
Koon J,
Collet C,
de Winter RJ,
Wykrzykowska JJ,
Stone G,
Popma J,
Kozuma K,
Tanabe K,
Serruys P,
Kimura T
October 10, 2016 | 10.4244/EIJV12I8A163
1
2
Latest news
AHEAD OF PRINT
Single antiplatelet therapy directly after PCI
FREE ARTICLE - Niels M.R. van der Sangen et al
February 3, 2023
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke